
    
      Prospective, randomised, double-blind, 3-arm parallel group comparison of DTx for pain
      (treatment A), control (treatment B) and an open standard care arm, over 6-8 weeks. An
      optional adaptive, multi-objective, multi-purpose, extension is included. Study devices will
      be delivered to the patient's home with instructions for use; patients will receive remote
      technical support.
    
  